1276/1/12/17 Pfizer Inc. and Pfizer Limited v Competition and Markets Authority

Pfizer Inc. and Pfizer Limited v Competition and Markets Authority

Case number:

1276/1/12/17 Registered: 7/2/2017


Summary of appeal published on 14 February 2017. A first case management conference (“CMC”) took place on 8 March 2017. At the first CMC the Chairman refused two third party applications to intervene ([2017] CAT 7) and ordered that the appeal be heard with Case 1276/1/12/17 in a hearing commencing on 30 October 2017. At the second CMC on 27 June 2017 the Chairman gave further case management directions. A pre-trial review listed for 28 September 2017 was vacated. The substantive hearing took place over 13 days between 30 October 2017 and 24 November 2017.

Judgment was handed down on 7 June 2018 ([2018] CAT 11). The version of the Judgment available on this website as of 24 July 2018 is the final non-confidential version. This version re-instates some text which was provisionally excised from the Judgment at the time of handing down pending confidentiality submissions from the parties.

On 25 July 2018 the Tribunal handed down a Ruling ([2018] CAT 12) refusing the parties permission to appeal and remitting the issue of abuse to the CMA for reconsideration in accordance with the Judgment.

Diary events for this case:

  • There are currently no forthcoming diary events for this case.
  • 8 Mar 2017 | 10.30am - Case management conference
  • 27 Jun 2017 | 10.30am - Case management conference
  • 30 Oct 2017 | 10.30am (time estimate of 4 weeks) - Hearing
  • 7 Jun 2018 | 2pm - Handing down of Judgment